Alpine Global Management, LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Alpine Global Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$9.85 - $16.83 $98,500 - $168,299	10,000 New	10,000 $145,000
Q3 2021 Nov 12, 2021	SELL	$17.11 - $24.49 $47,120 - $67,445	-2,754 Reduced 21.59%	10,000 $204,000
Q3 2021 Nov 12, 2021	BUY	$17.11 - $24.49 $218,220 - $312,345	12,754 New	12,754 $223,000
Q2 2021 Aug 13, 2021	SELL	$23.12 - $29.91 $231,200 - $299,100	-10,000 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$14.69 - $42.57 $146,900 - $425,700	10,000 New	10,000 $257,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $250M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpine Global Management, LLC with notifications on news.